
Vertex Pharmaceuticals Incorporated VRTX
$ 454.0
-0.88%
Annual report 2025
added 02-13-2026
Vertex Pharmaceuticals Incorporated Total Inventories 2011-2026 | VRTX
Annual Total Inventories Vertex Pharmaceuticals Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.69 B | 1.21 B | 739 M | 461 M | 353 M | 281 M | 168 M | 124 M | 112 M | 77.6 M | 57.2 M | 30.8 M | 14.1 M | 30.5 M | 112 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.69 B | 14.1 M | 363 M |
Quarterly Total Inventories Vertex Pharmaceuticals Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.63 B | 1.5 B | 1.36 B | 1.21 B | 1.08 B | 915 M | 813 M | 739 M | 689 M | 604 M | 535 M | 461 M | 388 M | - | 339 M | 353 M | 333 M | 322 M | 299 M | 281 M | 281 M | 281 M | 281 M | 168 M | 168 M | 168 M | 168 M | 124 M | 124 M | 124 M | 124 M | 112 M | 112 M | 112 M | 112 M | 77.6 M | 77.6 M | 77.6 M | 77.6 M | 57.2 M | 57.2 M | 57.2 M | 57.2 M | 30.8 M | 30.8 M | 30.8 M | 30.8 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 30.5 M | 30.5 M | 30.5 M | 30.5 M | 112 M | 112 M | 112 M | 112 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.63 B | 14.1 M | 303 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Milestone Pharmaceuticals
MIST
|
648 K | $ 1.36 | -20.0 % | $ 45.5 M | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.37 | -4.2 % | $ 350 M | ||
|
Axsome Therapeutics
AXSM
|
27.9 M | $ 156.92 | -1.23 % | $ 7.81 B | ||
|
AbCellera Biologics
ABCL
|
6.34 M | $ 3.4 | -3.68 % | $ 1.02 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
BioMarin Pharmaceutical
BMRN
|
1.3 B | $ 54.13 | -1.64 % | $ 10.4 B | ||
|
Cara Therapeutics
CARA
|
2.82 M | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
851 K | - | - | $ 3.74 B | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.52 | -5.59 % | $ 178 M | ||
|
Clovis Oncology
CLVS
|
13.7 M | - | -7.23 % | $ 13 M |